Testicular Cancer Clinical Trial
Official title:
The Effect of Training Based on the Health Belief Model on Testicular Self-Examination Awareness and Health Beliefs in Young Men
Verified date | March 2024 |
Source | Hitit University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to determine the effect of education based on the health belief model on testicular self-examination awareness and health beliefs in young men. H0 Hypothesis: Education based on the health belief model has no effect on the awareness of testicular self-examination and health beliefs about testicular self-examination of young men in the experimental and control groups. H1a Hypothesis: The training based on the health belief model will increase the awareness of young men in the experimental group about testicular self-examination compared to those in the control group. H1b Hypothesis: The training based on the health belief model will increase the mean scores of the sensitivity subscale of young men in the experimental group compared to those in the control group. H1c Hypothesis: The training based on the health belief model will increase the mean scores of the benefit subscale of young men in the experimental group compared to those in the control group. H1d Hypothesis: The training based on the health belief model will increase the mean scores of the seriousness subscale of young men in the experimental group compared to those in the control group. H1e Hypothesis: The training based on the health belief model will decrease the mean scores of the barriers subscale of young men in the experimental group compared to those in the control group. H1f Hypothesis: The training based on the health belief model will increase the mean scores of the health motivation subscale of young men in the experimental group compared to those in the control group. H1g Hypothesis: The training based on the health belief model will increase the mean scores of the self-efficacy subscale of young men in the experimental group compared to those in the control group.
Status | Active, not recruiting |
Enrollment | 120 |
Est. completion date | July 15, 2024 |
Est. primary completion date | November 20, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 15 Years to 35 Years |
Eligibility | Inclusion Criteria: - Being male - Being between the ages of 18 and 35 - Studying at Hitit University Faculty of Health Sciences - Not having attended a course or training program on testicular cancer. Exclusion Criteria: - Being under 18 years of age or over 35 years of age - Being a student in the Department of Nursing - Participating in a course or training program on testicular cancer - Having testicular cancer |
Country | Name | City | State |
---|---|---|---|
Turkey | Hitit University | Corum |
Lead Sponsor | Collaborator |
---|---|
Hitit University | Ondokuz Mayis University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Testicular Cancer Knowledge Test | The Testicular Cancer Knowledge Test will be administered as a follow-up test. | three months | |
Other | Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination | The Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination will be administered as a follow-up test. | three months | |
Primary | Demographic information and testicular cancer questionnaire | As a pre-test, a survey form consisting of 21 questions prepared by the researcher by scanning the literature. | one week | |
Primary | Testicular Cancer Knowledge Test | As a pre-test, a knowledge test consisting of 20 questions prepared by the researcher by scanning the literature.
There are true and false statements in the Testicular Cancer Knowledge Test. Participants are asked to evaluate these statements as true or false. Each correct answer is evaluated as 1 point, and an incorrect answer is evaluated as 0 points. |
one week | |
Primary | Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination | As a pre-test, Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination
The minimum score from the scale is 37 and the maximum is 185. Each dimension of the scale is evaluated separately, and as the score increases, positive behavior increases. |
one week | |
Secondary | For the control group, Testicular Cancer Knowledge Test | The Testicular Cancer Knowledge Test was administered as a posttest. | three months | |
Secondary | For the control group, Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination | The Health Beliefs Scale for Testicular Cancer and Testicular Self-Examination was administered as a posttest. | three months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00772694 -
Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
|
Phase 2 | |
Completed |
NCT00705094 -
Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
|
N/A | |
Terminated |
NCT00531687 -
Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
|
Phase 2 | |
Terminated |
NCT00820287 -
Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
|
N/A | |
Completed |
NCT00216801 -
Relationship of Ochratoxin A to Upper Urologic Cancers
|
N/A | |
Active, not recruiting |
NCT03142802 -
Low-Dose CT - Stage I Testicular Cancer
|
N/A | |
Recruiting |
NCT03232541 -
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
|
N/A | |
Completed |
NCT03557177 -
Clinical Characterisation of the Vascular Effects of Cis-platinum Based Chemotherapy in Patients With Testicular Cancer
|
||
Active, not recruiting |
NCT01783145 -
Shared Care Follow-up After Chemotherapy for Testicular Cancer
|
||
Recruiting |
NCT05611307 -
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
|
||
Completed |
NCT02573584 -
Vascular Fingerprint Validation Study
|
||
Recruiting |
NCT05670938 -
Follow-up After Surgery for Testicular Cancer
|
||
Recruiting |
NCT02994758 -
Development of Diagnostics and Treatment of Urological Cancers
|
N/A | |
Completed |
NCT02991209 -
Study of Testosterone vs Placebo in Testicular Cancer Survivors
|
Phase 2/Phase 3 | |
Completed |
NCT02602041 -
Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
|
||
Completed |
NCT02092740 -
REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg
|
N/A | |
Completed |
NCT01482741 -
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
|
N/A | |
Active, not recruiting |
NCT01242072 -
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
|
Phase 1 | |
Completed |
NCT01242631 -
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer
|
Phase 2 | |
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A |